While the expression of D1−5 (16–18) and 5-HT1A (19), 5-HT2A (20), 5-HT3A (21) receptors has previously been confirmed in PBMCs, few studies have measured the expression of these receptors in PBMCs of schizophrenia patients. This evidence concerns the gene HTR3A and schizophrenia.